Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Study links voter suppression to worsening health disparities

24

Oct 2026

Study links voter suppression to worsening health disparities

Public health researchers have long examined how societal forces can shape health outcomes. Decades after redlining was outlawed, for example, researchers continue to document its lasting effects on life expectancy, chronic disease and access to healthcare resources in many communities.

PFAS levels in United States drinking water may be underestimated

24

Oct 2026

PFAS levels in United States drinking water may be underestimated

Common ways of reporting perfluoroalkyl and polyfluoroalkyl substances (PFAS)-the man-made, so-called forever chemicals that pose environmental and health threats-could underestimate the concentration of PFAS in United States drinking water by as much as half, finds a study publishing October 23 in the Cell Press journal Cell Reports Sustainability.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.